{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:05:40Z","timestamp":1794575140679,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK57136"],"award-info":[{"award-number":["DK57136"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK57149"],"award-info":[{"award-number":["DK57149"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK56990"],"award-info":[{"award-number":["DK56990"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK57177"],"award-info":[{"award-number":["DK57177"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK57171"],"award-info":[{"award-number":["DK57171"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK571"],"award-info":[{"award-number":["DK571"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>We examined the association of attainment of diabetes remission in the context of a 12 year intensive lifestyle intervention with subsequent incidence of chronic kidney disease (CKD) and CVD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The Look AHEAD study was a multi-centre RCT comparing the effect of a 12 year intensive lifestyle intervention with that of diabetes support and education on CVD and other long-term health conditions. We compared the incidence of CVD and CKD among 4402 and 4132 participants, respectively, based on achievement and duration of diabetes remission. Participants were 58% female, and had a mean age of 59 years, a duration of diabetes of 6 year and BMI of 35.8 kg\/m<jats:sup>2<\/jats:sup>. We applied an epidemiological definition of remission: taking no diabetes medications and having HbA<jats:sub>1c<\/jats:sub> &lt;48 mmol\/mol (6.5%) at a single point in time. We defined high-risk or very high-risk CKD based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, and CVD incidence as any occurrence of non-fatal acute myocardial infarction, stroke, admission for angina or CVD death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants with evidence of any remission during follow-up had a 33% lower rate of CKD (HR 0.67; 95% CI 0.52, 0.87) and a 40% lower rate of the composite CVD measure (HR 0.60; 95% CI 0.47, 0.79) in multivariate analyses adjusting for HbA<jats:sub>1c<\/jats:sub>, BP, lipid levels, CVD history, diabetes duration and intervention arm, compared with participants without remission. The magnitude of risk reduction was greatest for participants with evidence of longer-term remission.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>Participants with type 2 diabetes with evidence of remission had a substantially lower incidence of CKD and CVD, respectively, compared with participants who did not achieve remission. This association may be affected by post-baseline improvements in weight, fitness, HbA<jats:sub>1c<\/jats:sub> and LDL-cholesterol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT00017953<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Data availability<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/repository.niddk.nih.gov\/studies\/look-ahead\/\">https:\/\/repository.niddk.nih.gov\/studies\/look-ahead\/<\/jats:ext-link><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-023-06048-6","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T01:02:16Z","timestamp":1705539736000},"page":"459-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2381-6822","authenticated-orcid":false,"given":"Edward W.","family":"Gregg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Bancks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Manalac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisa","family":"Maruthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Look AHEAD Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"issue":"11","key":"6048_CR1","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1111\/dme.14669","volume":"64","author":"MC Riddle","year":"2021","unstructured":"Riddle MC, Cefalu WT, Evans PH et al (2021) Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetologia 64(11):2359\u20132366. https:\/\/doi.org\/10.1111\/dme.14669","journal-title":"Diabetologia"},{"issue":"9","key":"6048_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","volume":"7","author":"R Taylor","year":"2019","unstructured":"Taylor R, Al-Mrabeh A, Sattar N (2019) Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol 7(9):726\u2013736. https:\/\/doi.org\/10.1016\/S2213-8587(19)30076-2","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"6048_CR3","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","volume":"61","author":"MJ Davies","year":"2018","unstructured":"Davies MJ, D\u2019Alessio DA, Fradkin J et al (2018) Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 61(12):2461\u20132498. https:\/\/doi.org\/10.1007\/s00125-018-4729-5","journal-title":"Diabetologia"},{"issue":"23","key":"6048_CR4","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1001\/jama.2012.67929","volume":"308","author":"EW Gregg","year":"2012","unstructured":"Gregg EW, Chen H, Wagenknecht LE et al (2012) Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 308(23):2489\u20132496. https:\/\/doi.org\/10.1001\/jama.2012.67929","journal-title":"JAMA"},{"issue":"5","key":"6048_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S2213-8587(19)30068-3","volume":"7","author":"MEJ Lean","year":"2019","unstructured":"Lean MEJ, Leslie WS, Barnes AC et al (2019) Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 7(5):344\u2013355. https:\/\/doi.org\/10.1016\/S2213-8587(19)30068-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"22","key":"6048_CR6","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1001\/jama.2014.5988","volume":"311","author":"L Sjostrom","year":"2014","unstructured":"Sjostrom L, Peltonen M, Jacobson P et al (2014) Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 311(22):2297\u20132304. https:\/\/doi.org\/10.1001\/jama.2014.5988","journal-title":"JAMA"},{"issue":"10","key":"6048_CR7","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1007\/s11695-017-2866-4","volume":"27","author":"B Sheng","year":"2017","unstructured":"Sheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L (2017) The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg 27(10):2724\u20132732. https:\/\/doi.org\/10.1007\/s11695-017-2866-4","journal-title":"Obes Surg"},{"issue":"10120","key":"6048_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"ME Lean","year":"2018","unstructured":"Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391(10120):541\u2013551. https:\/\/doi.org\/10.1016\/S0140-6736(17)33102-1","journal-title":"Lancet"},{"key":"6048_CR9","unstructured":"Diabetes UK. https:\/\/www.diabetes.org.uk\/about_us\/news\/nhs-low-calorie-diet-remission"},{"issue":"6","key":"6048_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.soard.2006.08.006","volume":"2","author":"JS Sampalis","year":"2006","unstructured":"Sampalis JS, Sampalis F, Christou N (2006) Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity. Surg Obes Relat Dis 2(6):587\u2013591. https:\/\/doi.org\/10.1016\/j.soard.2006.08.006","journal-title":"Surg Obes Relat Dis"},{"issue":"12","key":"6048_CR11","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.2337\/dc12-0193","volume":"35","author":"S Romeo","year":"2012","unstructured":"Romeo S, Maglio C, Burza MA et al (2012) Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care 35(12):2613\u20132617. https:\/\/doi.org\/10.2337\/dc12-0193","journal-title":"Diabetes Care"},{"key":"6048_CR12","doi-asserted-by":"publisher","unstructured":"Johnson BL, Blackhurst DW, Latham BB et al (2013) Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg 216(4):545\u2013556. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.12.019; (discussion 56\u20138)","DOI":"10.1016\/j.jamcollsurg.2012.12.019"},{"issue":"8","key":"6048_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.2337\/dc16-0194","volume":"39","author":"KJ Coleman","year":"2016","unstructured":"Coleman KJ, Haneuse S, Johnson E et al (2016) Long-term microvascular disease outcomes in patients with type 2 diabetes after bariatric surgery: evidence for the legacy effect of surgery. Diabetes Care 39(8):1400\u20131407. https:\/\/doi.org\/10.2337\/dc16-0194","journal-title":"Diabetes Care"},{"issue":"9833","key":"6048_CR14","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","volume":"379","author":"L Perreault","year":"2012","unstructured":"Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE (2012) Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet 379(9833):2243\u20132251. https:\/\/doi.org\/10.1016\/S0140-6736(12)60525-X","journal-title":"Lancet"},{"issue":"6","key":"6048_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00125-021-05401-x","volume":"64","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhang P, Wang J et al (2021) Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study. Diabetologia 64(6):1279\u20131287. https:\/\/doi.org\/10.1007\/s00125-021-05401-x","journal-title":"Diabetologia"},{"issue":"3","key":"6048_CR16","doi-asserted-by":"publisher","first-page":"e00280","DOI":"10.1002\/edm2.280","volume":"4","author":"H Hounkpatin","year":"2021","unstructured":"Hounkpatin H, Stuart B, Farmer A, Dambha-Miller H (2021) Association of type 2 diabetes remission and risk of cardiovascular disease in pre-defined subgroups. Endocrinol Diabetes Metab 4(3):e00280. https:\/\/doi.org\/10.1002\/edm2.280","journal-title":"Endocrinol Diabetes Metab"},{"issue":"2","key":"6048_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"RR Wing","year":"2013","unstructured":"Wing RR, Bolin P, Brancati FL et al (2013) Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 369(2):145\u2013154. https:\/\/doi.org\/10.1056\/NEJMoa1212914","journal-title":"N Engl J Med"},{"issue":"5","key":"6048_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/s0197-2456(03)00064-3","volume":"24","author":"DH Ryan","year":"2003","unstructured":"Ryan DH, Espeland MA, Foster GD et al (2003) Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 24(5):610\u2013628. https:\/\/doi.org\/10.1016\/s0197-2456(03)00064-3","journal-title":"Control Clin Trials"},{"issue":"5","key":"6048_CR19","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/oby.2006.84","volume":"14","author":"TA Wadden","year":"2006","unstructured":"Wadden TA, West DS, Delahanty L et al (2006) The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity(SilverSpring) 14(5):737\u2013752. https:\/\/doi.org\/10.1038\/oby.2006.84","journal-title":"Obesity(SilverSpring)"},{"issue":"17","key":"6048_CR20","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/archinternmed.2010.334","volume":"170","author":"RR Wing","year":"2010","unstructured":"Wing RR, Bahnson JL, Bray GA et al (2010) Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus four-year results of the look AHEAD trial. Arch Int Med 170(17):1566\u20131575. https:\/\/doi.org\/10.1001\/archinternmed.2010.334","journal-title":"Arch Int Med"},{"issue":"1","key":"6048_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S2213-8587(13)70025-1","volume":"1","author":"HC Gerstein","year":"2013","unstructured":"Gerstein HC, Werstuck GH (2013) Dysglycaemia, vasculopenia, and the chronic consequences of diabetes. Lancet Diabetes Endocrinol 1(1):71\u201378. https:\/\/doi.org\/10.1016\/S2213-8587(13)70025-1","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10322","key":"6048_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","volume":"399","author":"I Lingvay","year":"2022","unstructured":"Lingvay I, Sumithran P, Cohen RV, le Roux CW (2022) Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet 399(10322):394\u2013405. https:\/\/doi.org\/10.1016\/S0140-6736(21)01919-X","journal-title":"Lancet"},{"issue":"11","key":"6048_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","volume":"4","author":"EW Gregg","year":"2016","unstructured":"Gregg EW, Jakicic JM, Blackburn G et al (2016) Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol 4(11):913\u2013921. https:\/\/doi.org\/10.1016\/S2213-8587(16)30162-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"6048_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S2213-8587(20)30117-0","volume":"8","author":"S Taheri","year":"2020","unstructured":"Taheri S, Zaghloul H, Chagoury O et al (2020) Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 8(6):477\u2013489. https:\/\/doi.org\/10.1016\/S2213-8587(20)30117-0","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"6048_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/oby.20662","volume":"22","author":"The Look AHEAD Research Group","year":"2014","unstructured":"The Look AHEAD Research Group (2014) Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) 22(1):5\u201313. https:\/\/doi.org\/10.1002\/oby.20662","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"6048_CR26","doi-asserted-by":"publisher","first-page":"e15010","DOI":"10.1111\/dme.15010","volume":"40","author":"S Cassidy","year":"2023","unstructured":"Cassidy S, Trenell M, Stefanetti RJ et al (2023) Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT). Diabet Med 40(3):e15010. https:\/\/doi.org\/10.1111\/dme.15010","journal-title":"Diabet Med"},{"issue":"1","key":"6048_CR27","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1038\/s41467-021-25667-4","volume":"12","author":"C Durrer","year":"2021","unstructured":"Durrer C, McKelvey S, Singer J et al (2021) A randomized controlled trial of pharmacist-led therapeutic carbohydrate and energy restriction in type 2 diabetes. Nat Commun 12(1):5367. https:\/\/doi.org\/10.1038\/s41467-021-25667-4","journal-title":"Nat Commun"},{"issue":"4","key":"6048_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/dom.13915","volume":"22","author":"E Morris","year":"2020","unstructured":"Morris E, Aveyard P, Dyson P et al (2020) A food-based, low-energy, low-carbohydrate diet for people with type 2 diabetes in primary care: a randomized controlled feasibility trial. Diabetes Obes Metab 22(4):512\u2013520. https:\/\/doi.org\/10.1111\/dom.13915","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"6048_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.clnu.2016.07.003","volume":"36","author":"J Sato","year":"2017","unstructured":"Sato J, Kanazawa A, Makita S et al (2017) A randomized controlled trial of 130 g\/day low-carbohydrate diet in type 2 diabetes with poor glycemic control. Clin Nutr (Edinburgh, Scotland) 36(4):992\u20131000. https:\/\/doi.org\/10.1016\/j.clnu.2016.07.003","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"1","key":"6048_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/jdi.13619","volume":"13","author":"M Umphonsathien","year":"2022","unstructured":"Umphonsathien M, Rattanasian P, Lokattachariya S, Suansawang W, Boonyasuppayakorn K, Khovidhunkit W (2022) Effects of intermittent very-low calorie diet on glycemic control and cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a randomized controlled trial. J Diabetes Investig 13(1):156\u2013166. https:\/\/doi.org\/10.1111\/jdi.13619","journal-title":"J Diabetes Investig"},{"issue":"8","key":"6048_CR31","doi-asserted-by":"publisher","first-page":"e14395","DOI":"10.1111\/dme.14395","volume":"38","author":"G Thom","year":"2021","unstructured":"Thom G, Messow CM, Leslie WS et al (2021) Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT). Diabet Med 38(8):e14395. https:\/\/doi.org\/10.1111\/dme.14395","journal-title":"Diabet Med"},{"issue":"11","key":"6048_CR32","doi-asserted-by":"publisher","first-page":"e1003828","DOI":"10.1371\/journal.pmed.1003828","volume":"18","author":"M Captieux","year":"2021","unstructured":"Captieux M, Fleetwood K, Kennon B et al (2021) Epidemiology of type 2 diabetes remission in Scotland in 2019: a cross-sectional population-based study. PLoS Med 18(11):e1003828. https:\/\/doi.org\/10.1371\/journal.pmed.1003828","journal-title":"PLoS Med"},{"issue":"12","key":"6048_CR33","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.2337\/dc14-0874","volume":"37","author":"AJ Karter","year":"2014","unstructured":"Karter AJ, Nundy S, Parker MM, Moffet HH, Huang ES (2014) Incidence of remission in adults with type 2 diabetes: the diabetes & aging study. Diabetes Care 37(12):3188\u20133195. https:\/\/doi.org\/10.2337\/dc14-0874","journal-title":"Diabetes Care"},{"issue":"5","key":"6048_CR34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2337\/dc21-2136","volume":"45","author":"N Holman","year":"2022","unstructured":"Holman N, Wild SH, Khunti K et al (2022) Incidence and characteristics of remission of type 2 diabetes in England: a cohort study using the national diabetes audit. Diabetes Care 45(5):1151\u20131161. https:\/\/doi.org\/10.2337\/dc21-2136","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-023-06048-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-023-06048-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T12:05:12Z","timestamp":1707134712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-023-06048-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["6048"],"URL":"https:\/\/doi.org\/10.1007\/s00125-023-06048-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"11 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Look AHEAD data are available on request from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) data repository ().","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The Look AHEAD study was funded by the National Institutes of Health through cooperative agreements with the National Institute of Diabetes and Digestive and Kidney Diseases (DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135 and DK56992) Additional funding was provided by the National Heart, Lung and Blood Institute, the National Institute of Nursing Research, the National Center on Minority Health and Health Disparities, the NIH Office of Research on Women\u2019s Health and the US Centers for Disease Control and Prevention. This research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service provided personnel, medical oversight and use of facilities. The opinions expressed in this paper are those of the authors and do not necessarily reflect the views of the Indian Health Service or other funding sources. Additional support was received from the Johns Hopkins Medical Institutions Bayview General Clinical Research Center (M01RR02719), the Massachusetts General Hospital Mallinckrodt General Clinical Research Center and the Massachusetts Institute of Technology General Clinical Research Center (M01RR01066), the Harvard Clinical and Translational Science Center (RR025758-04), the University of Colorado Health Sciences Center General Clinical Research Center (M01RR00051) and Clinical Nutrition Research Unit (P30 DK48520), the University of Tennessee at Memphis General Clinical Research Center (M01RR0021140), the University of Pittsburgh General Clinical Research Center (GCRC) (M01RR000056), the Clinical Translational Research Center funded by Clinical & Translational Science Award UL1 RR 024153 and NIH grant DK 046204, the VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs and the Frederic C. Bartter General Clinical Research Center (M01RR01346). The following organisations have committed to make major contributions to the Look AHEAD programme: FedEx Corporation, Health Management Resources, LifeScan Inc. (a Johnson & Johnson Company), OPTIFAST\u00ae of Nestle HealthCare Nutrition Inc., Hoffmann-La Roche Inc., Abbott Nutrition and the Slim-Fast brand of Unilever North America. Some of the information contained herein was derived from data provided by the Bureau of Vital Statistics, New York City Department of Health and Mental Hygiene. EWG is supported by the Science Foundation Ireland (grant number 22\/RP\/10091), the UK National Institute of Health Research and the UK Royal Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"EWG conceptualised and led the writing of the manuscript. HC performed the analyses.\u00a0HC, MPB, RM, NM, MM and RW all contributed to researching, editing and revising key content. All authors approved the final version to be published. EWG is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}